Larimar Therapeutics
PA - Bala CynwydBiotechnology
Focus: Larimar Therapeutics is a small-molecule biotech focused on neurology, specifically Friedreich Ataxia. The company operates at a small scale with minimal public disclosure and appears to be in early clinical development.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Open Jobs
10+4 this month
Stable — net +4 jobs in 30d
4 added, 0 removed. Backfill posture.
Should You Work at Larimar Therapeutics?
AI assessmentBest suited for mission-driven scientists and operators seeking rare disease impact in an early-stage, under-resourced biotech with high execution risk but focused therapeutic focus.
Why Work Here
- Focused pipeline on rare neurology disorder (Friedreich Ataxia) with unmet patient need and potential for accelerated pathways.
- Growing hiring across regulatory, medical affairs, and business development suggests pipeline advancement and de-risking activities.
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
7 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Buccal Swabs, Blood Draws and Skin Punch Biopsy
Friedreich AtaxiaClinical Trials (1)
NCT05028764Determine Range of Tissue Frataxin Concentrations and Other Potential Biomarkers
N/AHelp build intelligence for Larimar Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.